Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples
Public ClinicalTrials.gov record NCT02795975. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.
Study identification
- NCT ID
- NCT02795975
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,766 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 14 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016 (Actual)
- Primary completion
- Mar 1, 2017 (Actual)
- Completion
- Mar 1, 2017 (Actual)
- Last update posted
- Mar 24, 2017
2016 – 2017
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Planned Parenthood of Southern New England, Inc | New Haven | Connecticut | 06511 | — |
| Segal Institute for Clinical Research | Miami | Florida | 33161 | — |
| Eskenazi Hospital - Indiana University School of Medicine | Indianapolis | Indiana | 46202 | — |
| Clinical Trials Management, LLC | Mandeville | Louisiana | 70471 | — |
| Beyer Research | Kalamazoo | Michigan | 49009 | — |
| Quality Clinical Research, Inc. | Omaha | Nebraska | 68114 | — |
| LabCorp | Burlington | North Carolina | 27215 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| Multnomah County Health Department, STD Clinic | Portland | Oregon | 97204 | — |
| Geneuity | Maryville | Tennessee | 37804 | — |
| Planned Parenthood Gulf Coast, Inc. | Houston | Texas | 77023 | — |
| Brownstone Clinical Trials | Irving | Texas | 75062 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| Tidewater Clinical Research, Inc. | Virginia Beach | Virginia | 23456 | — |
| University of Washington Center for AIDS & STD | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02795975, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2017 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02795975 live on ClinicalTrials.gov.